Erin Borger
Amministratore Delegato presso ExThera Medical Corp.
Posizioni attive di Erin Borger
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
ExThera Medical Corp.
 ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | 15/11/2023 | - |
Storia della carriera di Erin Borger
Precedenti posizioni note di Erin Borger
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| LONGEVERON INC. | Direttore/Membro del Consiglio | 12/02/2021 | 09/06/2023 |
| Independent Dir/Board Member | 12/02/2021 | 09/06/2023 | |
| National Parkinson Foundation, Inc. | Direttore/Membro del Consiglio | 12/01/2014 | - |
Formazione di Erin Borger
| Wofford College | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LONGEVERON INC. | Health Technology |
| Aziende private | 2 |
|---|---|
| National Parkinson Foundation, Inc. | Health Technology |
ExThera Medical Corp.
ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA. | Health Services |
- Borsa valori
- Insiders
- Erin Borger
- Esperienza
